Items where Author is "Thürlimann, B."

2020

Herrmann, C. and Ess, S. and Walser, E. and Frick, H. and Thürlimann, B. and Probst-Hensch, N. and Rothermundt, C. and Vounatsou, P.. (2020) Regional differences and trends in breast cancer surgical procedures and their relation to socioeconomic disparities and screening patterns. Journal of public health, 28 (1). pp. 71-80.

2013

Joerger, M. and Thürlimann, B. and Savidan, A. and Frick, H. and Rageth, C. and Lütolf, U. and Vlastos, G. and Bouchardy, C. and Konzelmann, I. and Bordoni, A. Probst-Hensch and Jundt, G. and Ess, S.. (2013) Treatment of breast cancer in the elderly : a prospective, population-based Swiss study. Journal of geriatric oncology, Vol. 4, H. 1. pp. 39-47.

2012

Joerger, M. and Thürlimann, B. and Savidan, A. and Frick, H. and Bouchardy, C. and Konzelmann, I. and Probst-Hensch, N. and Ess, S.. (2012) A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer. Clinical breast cancer, Vol. 12, H. 2. pp. 102-109.

2011

Joerger, M. and Riesen, W. F. and Thürlimann, B.. (2011) Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer. Journal of oncology pharmacy practice, Vol. 17, H. 3. pp. 292-294.

Ess, S. and Joerger, M. and Frick, H. and Probst-Hensch, N. and Vlastos, G. and Rageth, C. and Lütolf, U. and Savidan, A. and Thürlimann, B.. (2011) Predictors of state-of-the-art management of early breast cancer in Switzerland. Annals of oncology, Vol. 22, H. 3. pp. 618-624.

Joerger, M. and Templeton, A. and Köberle, D. and Engler, H. and Riesen, W. F. and Thürlimann, B.. (2011) Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer chemotherapy and pharmacology, Vol. 67, H. 5. pp. 1137-1144.

Joerger, M. and Thürlimann, B. and Huober, J.. (2011) Small HER2-positive, node-negative breast cancer : who should receive systemic adjuvant treatment? Annals of oncology, Vol. 22. pp. 17-23.

Goldhirsch, A. and Wood, W. C. and Coates, A. S. and Gelber, R. D. and Thürlimann, B. and Senn, H.-J. and Panel members, . (2011) Strategies for subtypes-dealing with the diversity of breast cancer : highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of oncology, Vol. 22, H. 8. pp. 1736-1747.

Viale, G. and Regan, M. M. and Dell'Orto, P. and Mastropasqua, M. G. and Maiorano, E. and Rasmussen, B. B. and MacGrogan, G. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Láng, I. and Thürlimann, B. and Mouridsen, H. and Mauriac, L. and Gelber, R. D. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S. and International Breast Cancer Study Groups, . (2011) Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology, Vol. 22, H. 10. pp. 2201-2207.

2010

Ess, S. and Savidan, A. and Frick, H. and Rageth, Ch and Vlastos, G. and Lütolf, U. and Thürlimann, B.. (2010) Geographic variation in breast cancer care in Switzerland. Cancer epidemiology, Vol. 34, H. 2. pp. 116-121.

2009

Huober, J. and Thürlimann, B.. (2009) Adjuvant! When the new world meets the old world. The Lancet oncology, Vol. 10, H. 11. pp. 1028-1029.

Rabaglio, M. and Sun, Z. and Price, K. N. and Castiglione-Gertsch, M. and Hawle, H. and Thürlimann, B. and Mouridsen, H. and Campone, M. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Pienkowski, T. and Nogaret, J.-M. and Láng, I. and Smith, I. and Gelber, R. D. and Goldhirsch, A. and Coates, A. S.. (2009) Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1489-1498.

Templeton, A. and Thürlimann, B. and Jörger, M.. (2009) Ixabepilon bei lokal fortgeschrittenem oder metastasiertem Mammakarzinom: Neue Behandlungsoptionen nach Taxanen und Anthrazyklinen. Schweizer Krebsbulletin, 2009, Nr. 2. pp. 114-117.

Jakesz, R. and Dubsky, P. and Eidtman, H. and Schem, C. and Lang, A. and Thürlimann, B.. (2009) Neue Erkenntnisse vom SABCS Expert Discussion. Breast Care, 4 (1). pp. 55-60.

Jörger, M. and J. Senn, H. and Thürlimann, B.. (2009) St.Gallen 2009 recommendations on the treatment of early breast cancer : consensus and controversy. Magazine of European Medical Oncology : MEMO; official journal of the Central European Cooperative Oncology Group (CECOG), Vol. 2, H. 4. pp. 229-231.

Goldhirsch, A. and Ingle, J. N. and Gelber, R. D. and Coates, A. S. and Thürlimann, B. and Senn, H.-J.. (2009) Thresholds for therapies : highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1319-1329.

2008

Thürlimann, B. and Bonnefoi, H. and Cameron, D. and Goldhirsch, A. and Herrmann, R. and Monnerat, C. and von Moos, R. and Pagani, O. and Perey, L. and Pestalozzi, B. and Rochlitz, C. and Suter, T.. (2008) Adjuvant therapy of HER2-positive breast cancer with trastuzumab. Senologie, Vol. 5. pp. 1-3.

Gruber, G. and Cole, B. F. and Castiglione-Gertsch, M. and Holmberg, S. B. and Lindtner, J. and Golouh, R. and Collins, J. and Crivellari, D. and Thürlimann, B. and Simoncini, E. and Fey, M. F. and Gelber, R. D. and Coates, A. S. and Price, K. N. and Goldhirsch, A. and Viale, G. and Gusterson, B. A.. (2008) Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of oncology, Vol. 19, H. 8. pp. 1393-1401.

Aapro, M. and Abrahamsson, P. A. and Body, J. J. and Coleman, R. E. and Colomer, R. and Costa, L. and Crinò, L. and Dirix, L. and Gnant, M. and Gralow, J. and Hadji, P. and Hortobagyi, G. N. and Jonat, W. and Lipton, A. and Monnier, A. and Paterson, A. H. G. and Rizzoli, R. and Saad, F. and Thürlimann, B.. (2008) Guidance on the use of bisphosphonates in solid tumours : recommendations of an international expert panel. Annals of oncology, Vol. 19, H. 3. pp. 420-432.

Regan, M. M. and Pagani, O. and Walley, B. and Torrisi, R. and Perez, E. A. and Francis, P. and Fleming, G. F. and Price, K. N. and Thürlimann, B. and Maibach, R. and Castiglione-Gertsch, M. and Coates, A. S. and Goldhirsch, A. and Gelber, R. D.. (2008) Premenopausal endocrine-responsive early breast cancer : who receives chemotherapy? Annals of oncology, Vol. 19, H. 7. pp. 1231-1241.

Bernhard, J. and Zahrieh, D. and Zhang, J. J. and Martinelli, G. and Basser, R. and Hürny, C. and Forbes, J. F. and Aebi, S. and Yeo, W. and Thürlimann, B. and Green, M. D. and Colleoni, M. and Gelber, R. D. and Castiglione-Gertsch, M. and Price, K. N. and Goldhirsch, A. and Coates, A. S.. (2008) Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, Vol. 98, no. 1. pp. 25-33.

von Moos, R. and Caspar, C. B. and Thürlimann, B. and Angst, R. and Inauen, R. and Greil, R. and Bergstrom, B. and Schmieding, K. and Pecherstorfer, M.. (2008) Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min : a randomized, open-label study. Annals of oncology, Vol. 19, H. 7. pp. 1266-1270.